Boardroom Alpha
10-K primary document
VREX · Annual Report (Form 10-K) · Filed November 18, 2025

Varex Imaging Corp10-K exhibit

exhibit211-10xk2025.htm
Document

Exhibit 21.1
VAREX IMAGING CORPORATION
LIST OF SUBSIDIARIES
as of October 3, 2025
NameJurisdiction of Incorporation
Direct Conversion LtdUnited Kingdom
Irradiation Systems, LLCNevada, USA
MeVis Medical Solutions AG (73.7%)Germany
MeVis Breastcare GmbH (86.1%)Germany
MeVis Breastcare GmbH & Co. KG (86.1%)Germany
Oy Varex Imaging Finland Ltd.Finland
Varex Imagens Brasil, Ltda.Brazil
Varex Imaging Americas CorporationIllinois, USA
Varex Imaging Arabia, LLC (75%)Saudi Arabia
Varex Imaging Deutschland AGGermany
Varex Imaging Equipment (China) Co., Ltd.China
Varex Imaging France SARLFrance
Varex Imaging Group Nederland B.V.Netherlands
Varex Imaging Holdings, Inc.Delaware, USA
Varex Imaging India Private LimitedIndia
Varex Imaging International AGSwitzerland
Varex Imaging International Holdings B.V.Netherlands
Varex Imaging Investments B.V.Netherlands
Varex Imaging Italia SrlItaly
Varex Imaging Japan, K.K.Japan
Varex Imaging Manufacturing India Private LimitedIndia
Varex Imaging Mexico, S. de R.L. de C.V. Mexico
Varex Imaging Nederland B.V.Netherlands
Varex Imaging Philippines, Inc.Philippines
Varex Imaging Spain S.L.Spain
Varex Imaging Sweden ABSweden
Varex Imaging Technologies (Beijing) Co. Ltd.China
Varex Imaging UK LimitedUnited Kingdom
Varex Imaging West Holdings, Inc.Delaware, USA
Varex Imaging West, LLCDelaware, USA
Virtual Media Integration, LLCDelaware, USA

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer